Immunosuppressant side effect profile does not differ between organ transplant types
Authors:
- 1 November 2001
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 15 (s6) , 46-50
Abstract
Transplantation has enhanced the quality of life of all transplant recipients, but concern remains regarding the side effects of immunosuppressant drugs. In order to respond to these concerns, a survey to ascertain the side effect profile of transplant recipients was undertaken to identify the impact of chronic immunosuppression on quality of life. A nationwide survey of solid organ transplant recipients was carried out using a newly developed immunosuppressant side effect survey. Kidney, kidney–pancreas, liver and heart recipients responded to the survey (n=505) and reflect the national distribution based on the UNOS data for organ type, recipient race and gender. The survey had four subscales: emotional burden, life/role responsibilities, mobility and GI distress. A fifth subscale included miscellaneous side effects that are more prevalent during the first 2 years post‐transplant. Frequency and severity of each side effect were coded on a scale of 0–4 from ‘no problem’ to ‘always’ a problem. The entire range of possible scores (0–160) was reported, reflecting adequate variability in the responses. The sample consisted of 51% males, 77% Caucasians, 15% African Americans, with the remaining 8% other races. There were 225 (44.5%) kidney, 147 (29.1%) liver, 101 (20%) heart and 32 (6.4%) pancreas included. Age ranged from 18–71 years with time since transplant 1–21 years. Overall frequency (12.1±6.08), severity (10.5±6.96) and weighted scores (25.4±19.9) were low suggesting that, as a whole, immunosuppressant side effects, while present, were not severe or troublesome for most patients. Side effect profiles appeared similar among organ types. Differences were detected in the GI distress subscale with the heart recipients reporting significantly less GI distress than liver recipients (13.8 vs. 19.2;P<0.05). Side effect impact on mobility tended to increase between time eras; however, no statistical significance was detected. Side effects are a concern among health‐care professionals; however, based on the results of this study, immunosuppressant‐related side effects are not detrimental to quality of life and show no differences between types of organ transplanted.Keywords
This publication has 9 references indexed in Scilit:
- Patient compliance in transplantation:Transplantation Proceedings, 1999
- Profiles of noncompliance in patients with a functioning renal transplant: a multicenter studyTransplantation Proceedings, 1999
- COMPLIANCE AND NONCOMPLIANCE IN PATIENTS WITH A FUNCTIONING RENAL TRANSPLANT: A MULTICENTER STUDY1,2Transplantation, 1998
- Symptom experience associated with maintenance immunosuppression after heart transplantation: Patients’ appraisal of side effectsHeart & Lung, 1998
- Differences Between Compliers and Partial Compliers: A Multicenter StudyTransplantation Proceedings, 1998
- Post kidney transplant quality of life prediction modelsClinical Transplantation, 1998
- Ethnic and gender variations in postrenal transplant physical symptomsTransplantation Proceedings, 1997
- DOES TRANSPLANTATION PRODUCE QUALITY OF LIFE BENEFITS?Transplantation, 1997
- NONCOMPLIANCE IN ORGAN TRANSPLANT RECIPIENTSTransplantation, 1990